Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-009876
Filing Date
2021-03-04
Accepted
2021-03-04 17:17:16
Documents
2
Period of Report
2021-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3777
2 EX-24 DOCUMENT attachment1.htm EX-24 4722
  Complete submission text file 0000899243-21-009876.txt   9981
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SOLENO THERAPEUTICS INC. 1235 RADIO ROAD, SUITE 110 REDWOOD CITY CA 94065
Business Address
Sinclair Andrew (Reporting) CIK: 0001762451 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38359 | Film No.: 21715283